Kenvue Inc. $KVUE Shares Sold by HighTower Advisors LLC

HighTower Advisors LLC trimmed its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 92.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 523,599 shares of the company’s stock after selling 6,136,004 shares during the period. HighTower Advisors LLC’s holdings in Kenvue were worth $9,032,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of KVUE. Arrowstreet Capital Limited Partnership acquired a new stake in shares of Kenvue during the second quarter worth $6,528,000. Jump Financial LLC increased its holdings in shares of Kenvue by 210.6% in the 2nd quarter. Jump Financial LLC now owns 54,823 shares of the company’s stock worth $1,147,000 after acquiring an additional 37,170 shares during the period. AXA S.A. increased its holdings in shares of Kenvue by 21.1% in the 2nd quarter. AXA S.A. now owns 48,892 shares of the company’s stock worth $1,023,000 after acquiring an additional 8,524 shares during the period. NewEdge Advisors LLC increased its holdings in shares of Kenvue by 219.1% in the 2nd quarter. NewEdge Advisors LLC now owns 97,481 shares of the company’s stock worth $2,040,000 after acquiring an additional 66,930 shares during the period. Finally, The Manufacturers Life Insurance Company increased its holdings in shares of Kenvue by 0.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,873,705 shares of the company’s stock worth $39,217,000 after acquiring an additional 10,885 shares during the period. 97.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on KVUE. Canaccord Genuity Group increased their price objective on shares of Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a report on Wednesday, February 18th. Argus raised shares of Kenvue to a “hold” rating in a report on Friday, March 6th. Weiss Ratings raised shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, May 8th. Zacks Research raised shares of Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, May 8th. Finally, Citigroup dropped their price objective on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and twelve have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $19.33.

Kenvue Stock Performance

Shares of KVUE opened at $17.55 on Tuesday. The firm has a 50-day moving average price of $17.41 and a 200 day moving average price of $17.44. The firm has a market capitalization of $33.69 billion, a PE ratio of 20.64, a P/E/G ratio of 1.33 and a beta of 0.55. The company has a quick ratio of 0.70, a current ratio of 0.98 and a debt-to-equity ratio of 0.67. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $24.00.

Kenvue (NYSE:KVUE) last announced its earnings results on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. The firm had revenue of $3.91 billion during the quarter, compared to analyst estimates of $3.84 billion. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. Kenvue’s revenue was up 4.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.24 EPS. On average, sell-side analysts anticipate that Kenvue Inc. will post 1.16 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th will be given a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a yield of 4.7%. The ex-dividend date is Wednesday, May 13th. Kenvue’s dividend payout ratio is currently 97.65%.

Insider Transactions at Kenvue

In related news, General Counsel Matthew Orlando sold 38,491 shares of the stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $17.66, for a total value of $679,751.06. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.59% of the stock is owned by corporate insiders.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.